Bausch Health Companies (BHC) Short term Debt (2009 - 2026)

Bausch Health Companies (BHC) has 17 years of Short term Debt data on file, last reported at $889.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt rose 215.25% year-over-year to $889.0 million; the trailing twelve-month figure through Mar 2026 stood at $889.0 million (up 215.25% YoY), and the FY2025 full-year result was $225.0 million, down 91.59% from the prior year.
• Short term Debt advanced to $889.0 million in Q1 2026, from $225.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $2.7 billion in Q4 2024 to a low of $150.0 million in Q2 2022.
• A 5-year average of $615.0 million and a median of $451.0 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt soared 494.22% in 2024 and sank 91.59% in 2025, its largest moves.
• Tracing BHC's Short term Debt over 5 years: stood at $432.0 million in 2022, then rose by 4.17% to $450.0 million in 2023, then soared by 494.22% to $2.7 billion in 2024, then slumped by 91.59% to $225.0 million in 2025, then surged by 295.11% to $889.0 million in 2026.
• Business Quant data shows BHC's Short term Debt at $889.0 million in Q1 2026, $225.0 million in Q4 2025, and $579.0 million in Q3 2025.